Kyle M. Kampman, M.D.
Kyle M. Kampman, M.D.
Professor of Psychiatry at the Hospital of the University of Pennsylvania and the Presbyterian Medical Center of Philadelphia
Department: Psychiatry
Contact information
University of Pennsylvania
Treatment Research Center
3900 Chestnut Street
Philadelphia, PA 19104
Treatment Research Center
3900 Chestnut Street
Philadelphia, PA 19104
Office: (215) 222-3200
Fax: (215) 386-6770
Fax: (215) 386-6770
Email:
kampman_k@mail.trc.upenn.edu
kampman_k@mail.trc.upenn.edu
Education:
B.A. (Chemistry)
Northwestern University, 1981.
MD
Tulane University, 1985.
Permanent linkB.A. (Chemistry)
Northwestern University, 1981.
MD
Tulane University, 1985.
Selected Publications
Ahmadi, Jamshid, Kampman, Kyle M., Oslin, David M., Pettinati, Helen M., Dackis, Charles, Sparkman, Thorne: Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment. American Journal on Addictions 18(1): 81-6, 2009.Lohoff, Falk W., Bloch, Paul J., Ferraro, Thomas N., Berrettini, Wade H., Pettinati, Helen M., Dackis, Charles A., O'Brien, Charles P., Kampman, Kyle M., Oslin, David W.: Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence. Neuroscience Letters 453(3): 199-203, 2009.
Franklin, Teresa R., Lohoff, Falk W., Wang, Ze, Sciortino, Nathan, Harper, Derek, Li, Yin, Jens, Will, Cruz, Jeffrey, Kampman, Kyle, Ehrman, Ron, Berrettini, Wade, Detre, John A., O'Brien, Charles P., Childress, Anna Rose: DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology 34(3): 717-28, 2009.
Ahmadi, Jamshid, Kampman, Kyle, Dackis, Charles, Sparkman, Thorne, Pettinati, Helen: Cocaine withdrawal symptoms identify "Type B" cocaine-dependent patients. American Journal on Addictions 17(1): 60-4, 2008.
Oslin, David W., Lynch, Kevin G., Pettinati, Helen M., Kampman, Kyle M., Gariti, Peter, Gelfand, Lois, Ten Have, Thomas, Wortman, Shoshana, Dundon, William, Dackis, Charles, Volpicelli, Joseph R., O'Brien, Charles P.: A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. Alcoholism: Clinical & Experimental Research 32(7): 1299-308, 2008.
Lohoff, Falk W., Weller, Andrew E., Bloch, Paul J., Nall, Aleksandra H., Ferraro, Thomas N., Kampman, Kyle M., Pettinati, Helen M., Oslin, David W., Dackis, Charles A., O'Brien, Charles P., Berrettini, Wade H.: Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. Neuropsychopharmacology 33(13): 3078-84, 2008.
Lohoff, Falk W., Bloch, Paul J., Weller, Andrew E., Nall, Aleksandra H., Doyle, Glenn A., Buono, Russell J., Ferraro, Thomas N., Kampman, Kyle M., Pettinati, Helen M., Dackis, Charles A., Oslin, David W., O'Brien, Charles P., Berrettini, Wade H.: Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence. Neuroscience Letters 440(3): 280-3, 2008.
Kampman, Kyle M.: The search for medications to treat stimulant dependence.[see comment] Addiction Science & Clinical Practice 4(2): 28-35, 2008.
Gariti, Peter, Levin, Sarah, Whittingham, Thomas, Barou, Daniela, Kampman, Kyle M., Lynch, Kevin, Halbert, Chanita Hughes, Alterman, Arthur: Why do those who request smoking treatment fail to attend the first appointment? Journal of Substance Abuse Treatment 35(1): 62-7, 2008.
Fairbairn, Catharine E., Dundon, William D., Xie, Hu, Plebani, Jennifer G., Kampman, Kyle M., Lynch, Kevin G.: Study blinding and correlations between perceived group assignment and outcome in a cocaine pharmacotherapy trial. American Journal on Addictions 17(5): 387-91, 2008.